MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Clinical trials for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy targets Hard-to-Treat cancers using Biopsy-Guided strategy
Disease control Recruiting nowThis study tests a treatment using donor immune cells (CAR-NK cells) designed to attack cancer. The specific target on the cancer cells is chosen based on a biopsy of the tumor or a blood test. The goal is to see if this approach is safe and can shrink or control advanced solid t…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Could a simple pill replace daily shots for blood clot prevention in cancer?
Disease control Recruiting nowThis study looks at whether lower doses of two common blood thinner pills (apixaban and rivaroxaban) work as well as standard daily injections to prevent dangerous blood clots in people with blood cancers like lymphoma, leukemia, and multiple myeloma. About 100 participants will …
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
AI chatbots could boost clinical trial enrollment in blood cancer patients
Knowledge-focused Recruiting nowThis study tests whether an AI-powered chatbot can help people with blood cancers (like leukemia, lymphoma, or multiple myeloma) better understand clinical trials and feel more willing to join one. About 196 participants will receive either standard education or AI-assisted educa…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: NA • Sponsor: Zhongnan Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Simple test may predict danger in new cancer therapies for seniors
Knowledge-focused Recruiting nowThis study looks at whether a quick, practical health assessment can help predict serious side effects in people aged 65 and older who are about to receive CAR-T cell or bispecific antibody therapy for certain blood cancers. Researchers will evaluate patients' mobility, memory, s…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC